Non-pathogenic F18
There is provided an isolated E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013 and attributed accession number 200613-01. There is also provided methods of using this strain for preventing edema disease or diarrhea caused by an F18 pathogenic E. coli infection in an animal.
1. A composition for animal consumption, comprising a live Escherichia coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013, and attributed accession number 200613-01 and a feed acceptable carrier, the composition being in lyophilized form and the strain being in an amount sufficient for administration of from about 5×10 6 to about 3×10 10 CFU per animal and for protecting the animal from disease caused by F18 infection.
2. The composition for animal consumption according to claim 1 , the strain being in an amount sufficient for administration of 5×10 8 CFU per animal.
3. The composition for animal consumption according to claim 1 , the strain being in an amount sufficient for administration of 1×10 9 CFU per animal.
4. The composition for animal consumption according to claim 1 , the strain being in an amount sufficient for administration of 5×10 9 CFU per animal.
5. The composition for animal consumption according to claim 1 , the strain being in an amount sufficient for administration of 3×10 8 CFU per animal.
6. The composition for animal consumption according to claim 1 , wherein the animal is a pig.
7. The composition for animal consumption according to claim 6 , wherein the pig is a post-weaning pig.
8. A composition for intestinal delivery in an animal, comprising a live Escherichia coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013, and attributed accession number 200613-01 and a feed acceptable carrier, the composition being in lyophilized form and the strain being in an amount sufficient for administration of from about 5×10 6 to about 3×10 10 CFU per animal and for protecting the animal from disease caused by F18 infection.
9. The composition according to claim 8 , the strain being in an amount sufficient for administration of 5×10 8 CFU per animal.
10. The composition according to claim 8 , the strain being in an amount sufficient for administration of 1×10 9 CFU per animal.
11. The composition according to claim 8 , the strain being in an amount sufficient for administration of 5×10 9 CFU per animal.
12. The composition according to claim 8 , the strain being in an amount sufficient for administration of 3×10 8 CFU per animal.
13. The composition according to claim 8 , wherein the animal is a pig.
14. The composition according to claim 13 , wherein the pig is a post-weaning pig.
15. The composition according to claim 8 , wherein the composition is adapted for reconstitution in water.